Intracellular Accumulation of Amyloidogenic Fragments of Amyloid-β Precursor Protein in Neurons with Niemann-Pick Type C Defects Is Associated with Endosomal Abnormalities

American Journal of Pathology

Volumn 164, Issue 3, 2004, Pages 975-985

  Jin, Lee Way ^a,b   Maezawa, Izumi ^a   Vincent, Inez ^a   Bird, Thomas ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL TRANSPORT; ENDOSOME; HIPPOCAMPUS; HISTOPATHOLOGY; LIPID STORAGE; MOUSE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPATHOLOGY; NEWBORN; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PYRAMIDAL NERVE CELL;

EID: 1242316263     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63185-9     Document Type: Article

References (71)

1. Liscum L, Klansek JJ: Niemann-Pick disease type C. Curr Opin Lipidol 1998, 9:131-135
2. Strauss JF, Liu P, Christenson LK, Watari H: Sterols and intracellular vesicular trafficking: lessons from the study of NPC1. Steroids 2002, 67:947-951
3. Vanier MT, Suzuki K: Niemann-Pick disease. Handbook of Clinical Neurology: Neurodystrophies and Neurolipidosis. Edited by HW Moser. Amsterdam, Elsevier Science, 1996, pp 132-162
4. Liscum L: Niemann-Pick type C mutations cause lipid traffic jam. Traffic 2000, 1:218-225
5. Mukherjee S, Maxfield FR: Cholesterol: stuck in traffic. Nat Cell Biol 1999, 1:E37-E38
6. Koo EH, Squazzo SL: Evidence that production and release of amyloid β-protein involves the endocytic pathway. J Biol Chem 1994, 269:17386-17389
7. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, Stokin GB, Koo EH: Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J Biol Chem 1999, 274:18851-18856
8. Jarrett JT, Berger EP, Lansbury Jr PT: The C-terminus of the β protein is critical in amyloidogenesis. Ann NY Acad Sci 1993, 695:144-148
9. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356
10. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA: Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000, 7:321-331
11. Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC: Diet-induced hypercholesterolemia enhances brain Aβ accumulation in transgenic mice. Neuroreport 2002, 13:455-459
12. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K: Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998, 95:6460-6464
13. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T: Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo. Proc Natl Acad Sci USA 2001, 98:5856-5861
14. Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE: A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2001, 8:890-899
15. Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, Chang TY, Tanzi RE, Kovacs DM: Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide. Nat Cell Biol 2001, 3:905-912
16. Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW: Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels. J Biol Chem 2002, 277:48508-48513
17. Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA, DeKosky ST, Lazo JS: 22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion. J Biol Chem 2003, 278:13244-13256
18. Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK: Acceleration of amyloid fibril formation by binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 1997, 272:22987-22990
19. Mukherjee S, Maxfield FR: Role of membrane organization and membrane domains in endocytic lipid trafficking. Traffic 2002, 1:203-211
20. Jin LW, Hearn M, Ogburn CE, Dang N, Nochlin D, Ladiges WC, Martin GM: Transgenic mice over-expressing the C-99 fragment of βPP with an α-secretase site mutation develop a myopathy similar to human inclusion body myositis. Am J Pathol 1998, 153:1679-1686
21. Kobayashi T, Beuchat MH, Lindsay M, Frias S, Palmiter RD, Sakuraba H, Parton RG, Gruenberg J: Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1999, 1:113-118
22. Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS: Evidence for p53-mediated modulation of neuronal viability. J Neurosci 1996, 16:6753-6765
23. Brewer GJ, Torricelli JR, Evege EK, Price PJ: Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J Neurosci Res 1993, 35:567-576
24. Skovronsky DM, Doms RW, Lee VM: Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J Cell Biol 1998, 141:1031-1039
25. Klafki HW, Wiltfang J, Staufenbiel M: Electrophoretic separation of βA4 peptides (1-40) and (1-42). Anal Biochem 1996, 237:24-29
26. Shie FS, LeBoeur RC, Jin LW: Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice. Neuroreport 2003, 14:123-129
27. Bu B, Klunemann H, Suzuki K, Li J, Bird T, Jin LW, Vincent I: Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis 2002, 11:285-297
28. Vuletic S, Jin LW, Marcovina SM, Peskind ER, Moller T, Albers JJ: Widespread distribution of phospholipid transfer protein (PLTP) in human central nervous system: evidence for PLTP synthesis by glia and neurons and for increased levels in Alzheimer's disease. J Lipid Res 2003, 44:1113-1123
29. Yamazaki T, Chang TY, Haass C, Ihara Y: Accumulation and aggregation of amyloid β-protein in late endosomes of Niemann-pick type C cells. J Biol Chem 2001, 276:4454-4460
30. Lange Y, Ye J, Rigney M, Steck T: Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles. J Biol Chem 2000, 275:17468-17475
31. Wolf D, Quon D, Wang Y, Cordell B: Identification and characterization of C-terminal fragments of the β-amyloid precursor produced in cell culture. EMBO J 1990, 9:2079-2084
32. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, Selkoe DJ: Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 1995, 270:9564-9570
33. Sopher BL, Fukuchi K, Smith AC, Leppig KA, Furlong CE, Martin GM: Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res Mol Brain Res 1994, 26:207-217
34. Jin LW, Hua DH, Shie FS, Maezawa I, Sopher B, Martin GM: Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death. J Mol Neurosci 2002, 19:57-61
35. Maruyama K, Terakado K, Usami M, Yoshikawa K: Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature 1990, 347:566-569
36. Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL, Neve RL: Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 1992, 89:10857-10861
37. Karten B, Vance DE, Campenot RB, Vance JE: Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick Cl-deficient neurons. J Neurochem 2002, 83:1154-1163
38. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R, Hartmann T: Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 2002, 22:1679-1689
39. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS: Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997, 19:939-945
40. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR: Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 2000, 156:15-20
41. Cataldo AM, Barnett JL, Pieroni C, Nixon RA: Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 1997, 17:6142-6151
42. Edmond J, Korsak RA, Morrow JW, Torok-Both G, Catlin DH: Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J Nutr 1991, 121:1323-1330
43. Turley SD, Burns DK, Rosenfeld CR, Dietschy JM: Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J Lipid Res 1996, 37:1953-1961
44. Cruz JC, Chang TY: Fate of endogenously synthesized cholesterol in Niemann-Pick type C1 cells. J Biol Chem 2000, 275:41309-41316
45. Karten B, Vance DE, Campenot RB, Vance JE: Trafficking of cholesterol from cell bodies to distal axons in Niemann Pick Cl-deficient neurons. J Biol Chem 2003, 278:4168-4175
46. German DC, Quintero EM, Liang C, Xie C, Dietschy JM: Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 2001, 105:999-1005
47. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL: Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 1990, 87:1561-1565
48. Ikin AF, Annaert WG, Takei K, De Camilli P, Jahn R, Greengard P, Buxbaum JD: Alzheimer amyloid protein precursor is localized in nerve terminal preparations to Rab5-containing vesicular organelles distinct from those implicated in the synaptic vesicle pathway. J Biol Chem 1996, 271:31783-31786
49. Marquez-Sterling NR, Lo AC, Sisodia SS, Koo EH: Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling. J Neurosci 1997, 17:140-151
50. Braak H, Braak E, Bohl J, Lang W: Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci 1989, 93:277-287
51. Mathews PM, Cataldo AM, Kao BH, Rudnicki AG, Qin X, Yang JL, Jiang Y, Picciano M, Hulette C, Lippa CF, Bird TD, Nochlin D, Walter J, Haass C, Levesque L, Fraser PE, Andreadis A, Nixon RA: Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Mol Med 2000, 6:878-891
52. Garver WS, Erickson RP, Wilson JM, Colton TL, Hossain GS, Kozloski MA, Heidenreich RA: Altered expression of caveolin-1 and increased cholesterol in detergent insoluble membrane fractions from liver in mice with Niemann-Pick disease type C. Biochim Biophys Acta 1997, 1361:272-280
53. Sawamura N, Morishima-Kawashima M, Waki H, Kobayashi K, Kuramochi T, Frosch MP, Ding K, Ito M, Kim TW, Tanzi RE, Oyama F, Tabira T, Ando S, Ihara Y: Mutant presenilin 2 transgenic mice. A large increase in the levels of Aβ 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin. J Biol Chem 2000, 275:27901-27908
54. Vanier MT: Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res 1999, 24:481-489
55. Sugimoto Y, Ninomiya H, Ohsaki Y, Higaki K, Davies JP, Ioannou YA, Ohno K: Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells. Proc Natl Acad Sci USA 2001, 98:12391-12396
56. Kakio A, Nishimoto SI, Yanagisawa K, Kozutsumi Y, Matsuzaki K: Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem 2001, 276:24985-24990
57. German DC, Liang CL, Song T, Yazdani U, Xie C, Dietschy JM: Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 2002, 109:437-450
58. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA: Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome. Differential effects of APOE genotype and presenilin mutations. Am J Pathol 2000, 157:277-286
59. Dreyer RN, Bausch KM, Fracasso P, Hammond LJ, Wunderlich D, Wirak DO, Davis G, Brini CM, Buckholz TM, Konig G, Kamarck ME, Tamburini PP: Processing of the pre-β-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. Eur J Biochem 1994, 224:265-271
60. Evin G, Cappai R, Li QX, Culvenor JG, Small DH, Beyreuther K, Masters CL: Candidate γ-secretases in the generation of the carboxyl terminus of the Alzheimer's disease βA4 amyloid: possible involvement of cathepsin D. Biochemistry 1995, 34:14185-14192
61. Hoffman KB, Bi X, Pham JT, Lynch G: β-Amyloid increases cathepsin D levels in hippocampus. Neurosci Lett 1998, 250:75-78
62. Wilson CA, Doms RW, Lee VM: Intracellular APP processing and Aβ production in Alzheimer disease. J Neuropathol Exp Neurol 1999, 58:787-794
63. Takahashi RH, Nam EE, Edgar M, Gouras GK: Alzheimer β-amyloid peptides: normal and abnormal localization. Histol Histopathol 2002, 17:239-246
64. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK: Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002, 161:1869-1879
65. Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG: Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci USA 1992, 89:7437-7441
66. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245:417-420
67. Oster-Granite ML, McPhie DL, Greenan J, Neve RL: Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci 1996, 16:6732-6741
68. Nalbantoglu J, Tirado-Santiago G, Lahsaini A, Poirier J, Goncalves O, Verge G, Momoli F, Welner SA, Massicotte G, Julien JP, Shapiro ML: Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 1997, 387:500-505
69. Berger-Sweeney J, McPhie DL, Arters JA, Greenan J, Oster-Granite ML, Neve RL: Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Brain Res Mol Brain Res 1999, 66:150-162
70. McPhie DL, Golde T, Eckman CB, Yager D, Brant JB, Neve RL: β-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Brain Res Mol Brain Res 2001, 97:103-113
71. Glabe C: Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 2001, 17:137-145